Automata

• LINQ Bench

  LINQ

Operating milestones

• Operating milestone

  2025-12-15 - Earlham Institute deployed LINQ across eleven instruments and five sequencing pipelines, reporting a fivefold throughput increase and an 80% reduction in manual touchpoints for sample quality control. - genomics quality-control workflow - Earlham Institute

  Source
• Operating milestone

  2024-06-11 - The Royal Marsden launched a LINQ clinical cancer-genomics facility with six robotic arms; Automata said it would double testing capacity and add about 2,000 tests per month. - clinical cancer genomics facility - Sharjah Clinical Genomics Laboratory

  Source

• Customer site

  2024-09-09 - Duncan NRI implemented LINQ to automate large-scale human cell-model culture and assays, with live microscopy and microelectrode-array integration. - Duncan NRI

  Source

• 2026-01-29 - Series C - $45M - Automata closes $45m Series C for AI-ready lab automation

  Automata closed a $45 million Series C led by Dimension to scale deployments and develop its data and closed-loop experimentation software. - source: automata.tech

• 2023-10-03 - $40M - Automata raises $40m to expand life-sciences lab automation

  Automata raised $40 million in a round led by Dimension with participation from A.P. Moller Holding and returning investors. - source: automata.tech

• 2022-02-22 - Series B - $50M - Automata raises $50 million Series B for life-sciences automation

  Automata raised $50 million in Series B financing to expand its lab-automation platform and commercial deployments in life sciences. - source: automata.tech

• 2019-03-19 - Series A - $7.4M - Automata raises £5.3M Series A to scale Eva production

  The company completed a financing round to advance its robotics or autonomy programme. - source: techcrunch.com

• Octopus Ventures - Lead - VC - 3 funding events - repeat backer - first seen 2022-02-22 - latest 2026-01-29
• Dimension - Lead - Unknown - 2 funding events - repeat backer - first seen 2023-10-03 - latest 2026-01-29
• Hummingbird - Participant - Unknown - 2 funding events - repeat backer - first seen 2022-02-22 - latest 2023-10-03
• Isomer Capital - Participant - VC - 2 funding events - repeat backer - first seen 2022-02-22 - latest 2023-10-03
• A.P. Moller Holding - Participant - Unknown - 1 funding event - first seen 2023-10-03
• ABB - Participant - Unknown - 1 funding event - first seen 2019-03-19
• ABB Technology Ventures - Participant - VC - 1 funding event - first seen 2022-02-22
• Aldea Ventures - Participant - VC - 1 funding event - first seen 2023-10-03
• Danaher Ventures - Participant - VC - 1 funding event - first seen 2026-01-29
• Entrepreneur First - Participant - Angel / Individual - 1 funding event - first seen 2019-03-19
• Entrepreneurs First - Participant - Angel / Individual - 1 funding event - first seen 2026-01-29
• firstminute Capital - Participant - VC - 1 funding event - first seen 2019-03-19
• HCVC - Participant - Unknown - 1 funding event - first seen 2019-03-19
• Hummingbird Ventures - Lead - VC - 1 funding event - first seen 2019-03-19
• In-Q-Tel - Participant - Unknown - 1 funding event - first seen 2022-02-22
• Latitude Ventures - Participant - VC - 1 funding event - first seen 2022-02-22
• LocalGlobe - Participant - Corporate / CVC - 1 funding event - strategic/corporate - first seen 2019-03-19
• Possible Ventures - Participant - VC - 1 funding event - first seen 2023-10-03
• Tru Arrow Partners - Participant - VC - 1 funding event - first seen 2026-01-29

• Mostafa ElSayed - Co-founder and CEO - ElSayed led Automata from affordable robotic arms into LINQ lab automation for life-sciences workflows, bringing computational design and robotics origins into laboratory…
• Jennifer Howson - Chief Financial Officer - Howson leads finance for Automata as the company scales LINQ lab automation across life-sciences workflows.
• Henni Roini - Chief of Staff - Roini supports Automata operating cadence and strategic execution as the company scales its lab automation platform.
• Joe Stringer - Executive Chairman and President of Corporate Development - Leads corporate development, strategic-account relationships and Automata's advisory board.
• Karian Lewis King - Global Head of People and Talent - Lewis King built Automata talent and HR systems through its robotics origins, pivot into life sciences automation, and US expansion.
• Rui Campos - Vice President of Product - Campos leads product direction and strategy for Automata as it develops LINQ Bench, LINQ Cloud, and broader lab automation workflows.
• Suryansh Chandra - Co-founder - Historical co-founder who helped establish Automata's computational-design and robotics origins.

Events

• 2026-10-07 - Partnership - Danaher plans autonomous laboratory with Automata robotic orchestration

  The workflow develops affinity reagents, including antibodies, and feeds experimental results back into models to improve later designs. Technologies come from Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies and Molecular Devices; Automata contributes device orchestration and robotic automation. The lab is designed to target up to eight times faster reagent discovery and a tenfold increase in annual reagent generation.

  Source
• 2026-02-09 - Demonstration - Automata demonstrates AI-ready lab automation workflows at SLAS 2026

  Automata listed SLAS Boston 2026 for February 9-11, 2026 at the Boston convention center and directed attendees to Booth 927. The company invited attendees to see the platform live and reserve a 15-minute booth walk-through. The booth page framed the demos around configurable, interoperable lab automation, AI-ready orchestration, and open data architecture.

  Source
• 2026-01-29 - Funding - Automata closes $45m Series C for AI-ready lab automation

  Dimension led the $45 million Series C, with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First and others. Automata said the capital would scale customer deployments, develop data and closed-loop experimentation software, and expand global operations. The round included a strategic investment partnership with Danaher, whose portfolio technologies are intended to integrate with Automata software.

  Source
• 2026-01-13 - Partnership - Automata and CellVoyant link LINQ to closed-loop cell-culture AI

  CellVoyant's AI interprets cell state and recommends protocol changes. Automata LINQ executes updated instructions across integrated instruments and robotic workcells. The partners target iterative, closed-loop workflows for advanced cell culture and cell-based therapeutic development.

  Source
• 2025-12-15 - Deployment - Earlham Institute deploys LINQ across genomics quality-control workflows

  The system measures volume, concentration and fragment size across six sample types. Earlham reported a fivefold throughput increase. The institute also reported an 80% reduction in manual touchpoints with LIMS-integrated data capture.

  Source
• 2024-09-09 - Deployment - Duncan NRI implements LINQ for human brain-cell research

  The system supports large-scale cell culture and cell-based assays. Integrated live microscopy and high-density microelectrode arrays monitor cell structure and function. The deployment targets research into neurological and neuropsychiatric disorders using stem-cell-derived models.

  Source
• 2024-06-11 - Deployment - Royal Marsden launches automated cancer-genomics facility with LINQ

  The facility is housed in the Sharjah Clinical Genomics Laboratory. Automata said the installation would double testing capacity and add about 2,000 tests per month. Automated sample pathways cover saliva, tissue biopsies, blood and bone marrow.

  Source
• 2024-02-09 - Deployment - Health Services Laboratories uses Automata for NHS pathology workflows

  The installation automates repetitive sample movement and instrument interactions. Automata framed the system around faster turnaround and more consistent laboratory execution. The deployment supports pathology services delivered to NHS patients.

  Source
• 2023-10-03 - Funding - Automata raises $40m to expand life-sciences lab automation

  Dimension led the $40 million round, with A.P. Moller Holding and returning investors Octopus Ventures, Hummingbird, Isomer Capital, Possible Ventures and Aldea Ventures participating. Automata said the proceeds would support geographic and team expansion across the US, UK and EMEA. The company reported 150% revenue growth and a twelvefold increase in live customer-system hours since its prior round.

  Source
• 2023-07-18 - Partnership - Royal Marsden selects Automata for clinical cancer-genomics automation

  The planned installation was designed to double genomic testing capacity. Automata said the system would add around 2,000 tests per month. The workflow covers next-generation sequencing sample processing for the North Thames Genomics Laboratory Hub.

  Source
• 2023-02-13 - Partnership - Francis Crick Institute partners with Automata on genomics automation

  The collaboration covers three genomics workflows. Automata's integrated system is intended to reduce manual touchpoints and increase walkaway time. The Crick receives early access to demonstrations and contributes feedback to product development.

  Source
• 2023-01-30 - Partnership - bit.bio partners with Automata on human-cell production automation

  The custom system targets a crucial step in bit.bio's production process. Automation turns the workflow into a more consistent and standardised process. The partners linked the installation to greater manufacturing capacity and speed for research and drug-discovery cells.

  Source
• 2022-02-22 - Funding - Automata raises $50 million Series B for life-sciences automation

  Octopus Ventures led the round. Hummingbird, Latitude Ventures, ABB Technology Ventures and Isomer Capital returned, with In-Q-Tel participating as a strategic investor. Automata linked the financing to scaling integrated automation for research, diagnostics and life-sciences production.

  Source
• 2019-03-19 - Funding - Automata raises £5.3M Series A to scale Eva production

  Hummingbird Ventures led the round. Hardware Club, firstminute Capital, LocalGlobe, ABB and Entrepreneur First participated. Contemporaneous reporting described the round as $7.4 million and said it brought Automata total funding to $9.5 million.

  Source
• 2015-01-12 - Company Formation - Automata Technologies is incorporated in London

  UK Companies House records Automata Technologies Limited as incorporated on 12 January 2015. Automata identifies Mostafa ElSayed and Suryansh Chandra as the two co-founders. The company began with affordable robotic arms before narrowing its focus to integrated life-sciences lab automation.

  Source

Profile notes

• Automata stopped treating an affordable standalone arm as the business and rebuilt around integrated laboratory infrastructure

  reviewed 2026-07-20 - Automata began with the Eva desktop robot arm for small, individual automation tasks across industries. The company later concluded that selling a low-cost arm without solving the surrounding workflow did not scale and narrowed its focus to integrated life-science laboratories, combining benches, orchestration software and data infrastructure in the LINQ platform. Current Automata deployments are not simply later generations of Eva; they reflect a different customer, scope and operating model.

  Source

Relationships

• CellVoyant

  Closed Loop Cell Culture Partner - Automata and CellVoyant integrate LINQ with FateView and FateDrive for closed-loop cell-culture workflows.

• Danaher

  Technology Partner - Danaher and Automata are developing robotic orchestration for an Abcam-based autonomous laboratory, with operation at scale targeted for early 2027.

• Beckman Coulter Life Sciences

  Lab Automation Partner - Beckman Coulter Life Sciences and Automata partnered on AI-ready laboratory automation workflows.

• The Francis Crick Institute

  Genomics Research Partner - The Francis Crick Institute partnered with Automata to automate genomics sample-preparation workflows in its Advanced Sequencing Facility.

• bit.bio

  Biotechnology Automation Partner - bit.bio partnered with Automata to automate a production step for iPSC-derived human-cell products.

Comparable profiles

• Hudson Lab Automation

  stack adjacency - Lab Automation Oem · Lab Automation Platform Builder · Lab Instrument Orchestration

• Telescope Innovations

  stack adjacency - Lab Automation Oem · Lab Instrument Orchestration

• Infera

  stack adjacency - Lab Instrument Orchestration

• Multiply Labs

  stack adjacency - Lab Instrument Orchestration

• Epistra

  stack adjacency - Lab Instrument Orchestration

• Chemspeed Technologies

  stack adjacency - Lab Automation Oem · Lab Automation Platform Builder

• Reshape Biotech

  stack adjacency - Lab Automation Platform Builder · Lab Instrument Orchestration

• Zeon Systems

  stack adjacency - Lab Automation Platform Builder

• Medra

  stack adjacency - Lab Automation Oem · Lab Automation Platform Builder

• Biosero

  stack adjacency - Lab Automation Platform Builder · Lab Instrument Orchestration

• Concerto Biosciences

  stack adjacency - Lab Automation Oem · Lab Automation Platform Builder

• Cell X Technologies

  stack adjacency - Lab Automation Oem · Lab Automation Platform Builder

Shared workflows

• Mecademic Industrial Robotics

  workflow adjacency - Lab Automation Handling

• XtalPi

  workflow adjacency - Lab Automation Handling

Context tags

• Automated lab workcell - Workflow
• Lab automation platform builder - Stack Layer
• Lab instrument orchestration - Capability
• Lab automation OEM - Stack Layer
• Lab automation handling - Workflow
• Research labs - Customer Environment
• Lab automation sites - Customer Environment